| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/12/1986 | EP0171270A2 Process for the preparation of angiotensin-II analogues substituted in the 1-, 5- and 8-positions |
| 02/12/1986 | EP0171176A2 Bone repair using collagen |
| 02/12/1986 | EP0171147A2 Anti-diabetic compounds |
| 02/12/1986 | EP0171083A2 Monoclonal antibody, process for preparing same, reagent for detecting cancer antigen containing the monoclonal antibody and process for preparing same |
| 02/12/1986 | EP0171024A1 Genetic engineering process for the production of hirudins, and agents for carrying out said process |
| 02/12/1986 | EP0170917A1 Novel human interferon-gamma polypeptide derivative |
| 02/12/1986 | EP0170843A1 Synergistic mixtures of interferons and tumour-necrose factor |
| 02/12/1986 | EP0170775A1 Derivatives of bicyclic amino acids, processes for their preparation, agents containing them and their use as well as bicyclic amino acids as intermediates and process for their preparation |
| 02/11/1986 | US4569927 GnRH Antagonists IV |
| 02/11/1986 | US4569926 Injection into blood stream |
| 02/11/1986 | US4569908 Multiclass hybrid interferons |
| 02/11/1986 | US4569907 Thiopeptolide substrates for vertebrate collagenase |
| 02/11/1986 | US4569794 Process for purifying proteins and compounds useful in such process |
| 02/11/1986 | US4569792 Peptides |
| 02/11/1986 | US4569791 Peptides |
| 02/11/1986 | US4569790 Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions |
| 02/11/1986 | US4569789 Amino-sulfhydrol cross-linked reagents as time-release agents |
| 02/11/1986 | CA1200515A1 Manufacture and expression of large structural genes |
| 02/11/1986 | CA1200506A1 Caries inhibition |
| 02/11/1986 | CA1200489A1 Method of preparation of human urine origin colony- stimulating factor and kallikrein |
| 02/11/1986 | CA1200488A1 Medicinal compositions, foods and beverages having therapeutic effects on diseases of circulatory system and digestive system |
| 02/05/1986 | EP0170623A2 Novel pharmaceutical use of (NVA)2-cyclosporine |
| 02/05/1986 | EP0170550A1 Biologically active substances obtained from bovine casein, process for their preparation and compositions containing them |
| 02/05/1986 | EP0170502A2 Improvements in in vitro fertilisation |
| 02/05/1986 | EP0170496A2 Vaccine against urinary tract infection |
| 02/05/1986 | EP0170247A2 Hemoglobin-containing liposomes and process for preparing the same |
| 02/05/1986 | EP0170204A2 Genetic sequences, type I interferon peptide coded by them, and these organisms producing the same |
| 02/05/1986 | EP0170115A1 Thrombus dissolvent |
| 02/05/1986 | EP0170048A2 Aliphatic thioethers |
| 02/05/1986 | EP0169907A1 Process for preparing sugar-added polypeptides |
| 02/04/1986 | USH22 Synergistic effect of chemotherapeutic agents on beta-interferon |
| 02/04/1986 | US4568725 Products based on polymers or copolymers substituted by groups having selective affinity towards products involved in blood plasma coagulation and process for preparing same |
| 02/04/1986 | US4568666 Carboxylalkyl peptide derivatives |
| 02/04/1986 | US4568665 Protein compounds |
| 02/04/1986 | US4568646 Preparation of antibiotic LL-D05139β from cultures of Glycomyces harbinensis, gen. nov., sp. nov. |
| 02/04/1986 | US4568545 Anticoagulants, earthworm tissue extracts |
| 02/04/1986 | US4568544 Adding lysine, ornithine, or salts thereof |
| 02/04/1986 | US4568543 Ukrokinase, hyaluronidase |
| 01/30/1986 | WO1986000646A1 Monoclonal antibodies and their use |
| 01/30/1986 | WO1986000645A1 Monoclonal antibodies and their use |
| 01/30/1986 | WO1986000644A1 Monoclonal antibodies and their use |
| 01/30/1986 | WO1986000643A1 Monoclonal antibodies and their use |
| 01/30/1986 | WO1986000642A1 Monoclonal antibodies and their use |
| 01/30/1986 | WO1986000641A1 Monoclonal antibodies and their use |
| 01/30/1986 | WO1986000639A1 Lymphokine production and purification |
| 01/30/1986 | WO1986000622A1 Hexapeptide |
| 01/30/1986 | WO1986000621A1 Hexapeptide |
| 01/30/1986 | WO1986000619A1 Prepro insulin-like growth factors i and ii |
| 01/30/1986 | WO1986000618A1 Condensed 7-membered ring compounds and process for their preparation |
| 01/30/1986 | WO1986000617A1 Condensed 7-membered ring compounds and process for their preparation |
| 01/30/1986 | WO1986000531A1 Gamma-interferon composition |
| 01/30/1986 | WO1986000530A1 Process for preparing gamma globulin suitable for intravenous administration |
| 01/30/1986 | WO1986000528A1 Cloned gene and method for making and using the same |
| 01/30/1986 | WO1986000527A1 Cell-delivery agent |
| 01/30/1986 | WO1986000526A1 Process for adapting soluble bone protein for use in stimulating osteoinduction |
| 01/30/1986 | WO1986000525A1 Process for the preparation of a pharmaceutical composition influencing the tissue metabolism and having a regenerating action |
| 01/30/1986 | WO1986000523A1 Dietary supplement and method of minimizing effects of infection through diet |
| 01/29/1986 | EP0169601A1 Ocytocic composition |
| 01/29/1986 | EP0169566A1 Novel CSF and method for obtaining the same |
| 01/29/1986 | EP0169562A1 Recominant factor VIII-R |
| 01/29/1986 | EP0169239A1 HUMAN ERYTHROPOIETIN cDNA CLONES |
| 01/28/1986 | US4567167 Inhibitor of angiotendin converting enzyme |
| 01/28/1986 | US4567162 Biologically active heptapeptides |
| 01/28/1986 | US4567044 Liniment composition |
| 01/28/1986 | CA1199872A1 Pharmaceutical methods and compositions |
| 01/22/1986 | EP0169166A1 Process for hydrolysing proteic materials of animal or vegetal origin. |
| 01/22/1986 | EP0169115A1 Immunologically active substances, process for preparing them from bovine fibrinogen and compositions containing them |
| 01/22/1986 | EP0169114A2 Human alpha-1-antitrypin derivatives and process for their preparation |
| 01/22/1986 | EP0169112A1 Imidazolides, process for obtaining them and their use as intermediates in the synthesis of cytotoxic conjugates |
| 01/22/1986 | EP0169111A1 Cytotoxic conjugates useful in therapy, and process for obtaining them |
| 01/22/1986 | EP0169016A2 Polypeptide cartilage-inducing factors found in bone |
| 01/22/1986 | EP0168832A2 Pharmaceutical composition containing a tetrapyrrole compound as active ingredient and process for the production of the tetrapyrrole compound |
| 01/22/1986 | EP0168831A2 Tetrapyrrole compounds and process for the production of same and a pharmaceutical composition containing same |
| 01/22/1986 | EP0168830A2 Immunoglobulin preparation in combination with another pharmacologically active preparation for use in the treatment of diseases |
| 01/22/1986 | EP0168769A2 Process for preparing carboxyalkyl dipeptides |
| 01/22/1986 | EP0168651A1 Antiviral protein, method for producing the same and pharmaceutical compositions containing such protein |
| 01/22/1986 | EP0168626A1 Composition for the manufacture of a medicament for the therapeutic treatment of trauma of the skin |
| 01/22/1986 | EP0168506A1 Process for preparing gamma globulin suitable for intravenous administration |
| 01/22/1986 | EP0168425A1 Parenteral nutrition with medium and long chain triglycerides |
| 01/22/1986 | EP0088752B1 Antigenic peptide compound |
| 01/21/1986 | US4565819 Substituted imino diacids, their preparation and pharmaceutical compositions which contain them |
| 01/21/1986 | US4565805 Pharmaceutical preparation for the treatment of peptic ulcer |
| 01/21/1986 | US4565804 GnRH Antagonists VI |
| 01/21/1986 | US4565789 Cell matrix receptor system and use in cancer diagnosis and management |
| 01/21/1986 | US4565687 Monoclonal antibodies specific for the unbound β subunit of human chorionic gonadotropin |
| 01/21/1986 | US4565653 Bactericides |
| 01/21/1986 | US4565651 Stabilizer, saccharides, amino acids, sugar alcohols |
| 01/21/1986 | US4565580 Substrate consisting of regenerated collagen fibrils and method of manufacturing same |
| 01/21/1986 | CA1199597A1 Process for the industrial preparation of collagenous materials from human placental tissues, collagenous materials thus obtained and applications thereof as biomaterials |
| 01/21/1986 | CA1199580A1 Collagen implant material and method for augmenting soft tissue |
| 01/21/1986 | CA1199579A1 Process for the purification of physiologically active substance having antitumor activity |
| 01/21/1986 | CA1199578A1 Tissue culture medium |
| 01/16/1986 | WO1986000338A1 Growth-related hormone |
| 01/16/1986 | WO1986000337A1 HUMAN alpha1-ANTITRYPSIN DERIVATIVES AND PREPARATION PROCESS THEREOF |
| 01/16/1986 | WO1986000233A1 Apparatus and methodology for pulsed administration of growth promoting agents |
| 01/16/1986 | WO1986000229A1 Dialysis solutions containing cross-linked gelatin |
| 01/15/1986 | EP0168342A1 Process for the preparation of thrombin inhibitors |
| 01/15/1986 | EP0168217A2 Method of extracting tumor necrosis factor-like substance |
| 01/15/1986 | EP0168214A2 Tumor necrosis factor, methods for its preparation, compositions containing it, DNA encoding it and assay method using such DNA |
| 01/15/1986 | EP0168063A2 Peptide usable as an intermediate for the production of a physiologically active peptide |